Steroid-Free Vtama Cream Approved for Plaque Psoriasis
The approval was based on data from 2 identical phase 3 studies, PSOARING 1 and PSOARING 2.
All articles by Diana Ernst, RPh
Hidden Drugs Found in Supplements Promoted for Musculoskeletal Conditions
Laboratory analyses revealed certain Artri and Ortiga products contain undeclared drug ingredients.
Dupilumab Under Review for Atopic Dermatitis in Kids 5 Years and Under
The sBLA is supported by data from the phase 3 LIBERTY AD PRESCHOOL study.
FDA Greenlights Use of Veklury for Outpatient COVID-19 Treatment
Veklury is a nucleotide analogue with broad spectrum antiviral activity.
FDA Approves Cortrophin Gel for Certain Chronic Autoimmune Disorders
Cortrophin Gel is a purified adrenocorticotropic hormone.
Acne Vulgaris Treatment Winlevi Now Available
The approval of Winlevi was based on data from 2 double-blind, vehicle-controlled phase 3 trials in 1440 patients with facial acne vulgaris.
Travel Restrictions Hinder Bimekizumab BLA Review
Bimekizumab is an investigational humanized monoclonal IgG1 antibody that selectively inhibits both interleukin (IL)-17A and IL-17F.
FDA: Needle-Free Devices Should Not Be Used to Inject Dermal Fillers
These “pens” use high pressure to force substances into the body.
Inhaled Corticosteroids May Reduce Severity, Frequency of Recurrent Croup
Patients who had more than 5 episodes of croup were more likely to benefit from inhaled corticosteroids.
Low Dose Naltrexone Designated Orphan Drug for Complex Regional Pain Syndrome
Anecdotal reports suggest that naltrexone, an opioid antagonist, may alleviate symptoms associated with CRPS.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...